An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific cholesterol-raising conditions.

Novo completed its maiden drill program at the Clone prospect as part of the Tibooburra Gold Project, in May 2025. The program comprised 14 RC holes for 1,984 m, testing 500 m of strike. Drilling ...